share_log

Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With Their Favorable 37% Return Over the Last Five Years

Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With Their Favorable 37% Return Over the Last Five Years

過去五年中,強生(紐交所股票代碼:JNJ)的投資者將會爲他們獲得的令人滿意的37%的回報感到高興。
Simply Wall St ·  08/07 06:33

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than that, you probably want to see it rise more than the market average. Unfortunately for shareholders, while the Johnson & Johnson (NYSE:JNJ) share price is up 19% in the last five years, that's less than the market return. The last year has been disappointing, with the stock price down 8.2% in that time.

當您長期購買並持有股票時,肯定希望它能提供正面的回報。但更重要的是,您可能希望看到它的增長超過市場平均水平。不幸的是,對於股東而言,儘管強生(紐交所:JNJ)股價在過去五年中上漲了19%,但這低於市場回報。過去一年令人失望,股價在這段時間內下跌了8.2%。

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

現在值得更詳細地了解該公司的基本面,因爲這將幫助我們判斷長期股東回報是否與基礎業務的表現相匹配。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

雖然市場是一個強大的定價機制,但股價反映的不僅僅是企業的基本業績,還有投資者的情緒。一個不完美但簡單的方式來考慮公司市場意識的變化是比較每股收益(EPS)的變化和股價的變化。

During five years of share price growth, Johnson & Johnson achieved compound earnings per share (EPS) growth of 2.1% per year. This EPS growth is lower than the 4% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth.

在股價增長的五年中,強生公司的每股收益(EPS)複合增長率爲2.1%每年。這種EPS增長低於股價平均年增長4%。這表明現今市場參與者更看好該公司。考慮到其增長記錄,這並不令人驚訝。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。

big
NYSE:JNJ Earnings Per Share Growth August 7th 2024
紐交所:JNJ每股收益增長2024年8月7日

We know that Johnson & Johnson has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

我們知道強生公司近期已經改善了其底線,但它將增長收入嗎?如果您感興趣,您可以查看這份免費報告以查看共識收入預測。

What About Dividends?

那麼分紅怎麼樣呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Johnson & Johnson's TSR for the last 5 years was 37%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

除衡量股票回報外,投資者還應考慮總股東回報(TSR)。TSR包括任何分拆或折價增資的價值,以及任何據假定股利已被再投資的股息。因此,對於支付豐厚股息的公司,TSR通常比股票回報高得多。事實上,強生公司過去5年的TSR爲37%,超過了先前提到的股票回報。而股息付款在很大程度上解釋了這種背離情況!

A Different Perspective

不同的觀點

Johnson & Johnson shareholders are down 5.3% for the year (even including dividends), but the market itself is up 16%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn't be so upset, since they would have made 6%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 1 warning sign for Johnson & Johnson that you should be aware of before investing here.

強生公司的股東們今年(包括股息)虧損了5.3%,而市場自身上漲了16%。但是,請記住,即使是最好的股票有時也會在十二個月的時間內表現不佳。從更長遠的投資者的角度來看,他們在過去五年中每年都會獲得6%的回報。如果基本數據繼續表明長期可持續的增長,當前的拋售可能值得考慮。雖然考慮到市場條件對股價的不同影響非常值得,但還有其他因素更加重要。例如,我們發現了一種強生公司的1個警告信號,在投資之前應該注意。

But note: Johnson & Johnson may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但請注意:強生公司可能不是最好的股票購買選擇。因此,請查看此過去盈利增長(以及進一步增長預測)有趣的公司的免費列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論